ASP Isotopes (NASDAQ:ASPI) Stock Price Up 8% – What’s Next?

ASP Isotopes Inc. (NASDAQ:ASPI)’s share price shot up 8% on Friday . The company traded as high as $4.54 and last traded at $4.5460. 510,470 shares changed hands during trading, a decline of 90% from the average session volume of 5,182,098 shares. The stock had previously closed at $4.21.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a report on Friday, March 27th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $13.00.

ASP Isotopes Stock Performance

The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14. The company has a 50 day moving average price of $5.16 and a 200 day moving average price of $6.98. The company has a market capitalization of $490.47 million, a price-to-earnings ratio of -3.40 and a beta of 3.59.

Insider Activity at ASP Isotopes

In other news, COO Robert Ainscow sold 8,438 shares of the firm’s stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $5.44, for a total value of $45,902.72. Following the completion of the sale, the chief operating officer directly owned 1,537,817 shares in the company, valued at $8,365,724.48. This trade represents a 0.55% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 14.40% of the stock is currently owned by corporate insiders.

Institutional Trading of ASP Isotopes

Several large investors have recently made changes to their positions in ASPI. Quantbot Technologies LP acquired a new stake in shares of ASP Isotopes in the 3rd quarter valued at about $34,000. BNP Paribas Financial Markets grew its stake in shares of ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after buying an additional 2,548 shares during the period. IFP Advisors Inc acquired a new stake in shares of ASP Isotopes in the 4th quarter valued at about $48,000. Pictet Asset Management Holding SA acquired a new stake in shares of ASP Isotopes in the 4th quarter valued at about $61,000. Finally, Close Asset Management Ltd acquired a new stake in shares of ASP Isotopes in the 3rd quarter valued at about $72,000. 16.80% of the stock is currently owned by institutional investors and hedge funds.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.